Live from the NIH registry
Studies recruiting near Riverside right now
Top 25 of 934 recruiting studies, sorted by proximity — each links to its official registry page
Effect of Electro-Acupuncture on Blood Pressure
Hypertension
N/A
Interventional 160 participants sought
UCIMedical Center — Orange, California (28.3 mi)
· Sponsor: University of California, Irvine
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL)
Phase 1
Interventional 248 participants sought
University of California Irvine — Orange, California (28.3 mi)
· Sponsor: Nurix Therapeutics, Inc.
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Metastatic Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma
Phase 3
Interventional 1,524 participants sought
UC Irvine Health/Chao Family Comprehensive Cancer Center — Orange, California (28.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
Infinity Clinical Research — Norco, California (8.8 mi)
· Sponsor: Crystalys Therapeutics
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Geographic Atrophy, Macular Degeneration
N/A
Observational 500 participants sought
Retina Consultants of Southern CA — Redlands, California (14.6 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
Adjuvant Sacituzumab Govitecan and Nivolumab in Muscle-Invasive Urothelial Carcinoma at High-Risk Recurrence
Urothelial Carcinoma, Muscle-invasive Bladder Cancer
Phase 2
Interventional 23 participants sought
Chao Family Comprehensive Cancer Center, University of California, Irvine — Orange, California (28.3 mi)
· Sponsor: University of California, Irvine
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 188 participants sought
Kaiser Permanente-Ontario — Ontario, California (17.0 mi)
· Sponsor: National Cancer Institute (NCI)
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets
Type 2 Diabetes
Phase 2
Interventional 60 participants sought
Catalina Research Institute, LLC — Montclair, California (19.4 mi)
· Sponsor: Biomea Fusion Inc.
A Long-Term Observational Study of Patients With Fucosidosis
Fucosidosis
N/A
Observational 57 participants sought
Children's Hospital of Orange County — Orange, California (28.3 mi)
· Sponsor: JCR Pharmaceuticals Co., Ltd.
Comparison of Uncomplicated Candidemia Therapy Duration in Children
Invasive Candidiasis
N/A
Interventional 420 participants sought
Children's Hospital of Orange County — Orange, California (28.3 mi)
· Sponsor: Arkansas Children's Hospital Research Institute
PhI Pilot Study Pafolacianine Inject for Intraoperative Imaging on Outcomes of GI Cancer Peritoneal Carcinomatosis
Gastrointestinal Cancer, Peritoneal Carcinomatosis
EARLY/Phase 1
Interventional 10 participants sought
Chao Family Comprehensive Cancer Center, University of California, Irvine — Orange, California (28.3 mi)
· Sponsor: University of California, Irvine
Wound Irrigation With Saline Versus Hypodilute-chlorhexidine After Cesarean Section (WISHES Study)
Cesarean Section Complications, Cesarean Section; Infection
N/A
Interventional 400 participants sought
Loma Linda University — Loma Linda, California (10.8 mi)
· Sponsor: Loma Linda University
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
Solid Tumor, Advanced Cancer
Phase 1
Interventional 330 participants sought
Stern Center for Cancer Clinical Trials and Research — Orange, California (28.3 mi)
· Sponsor: I-Mab Biopharma US Limited
A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)
Active Rheumatoid Arthritis
Phase 2
Interventional 180 participants sought
Solace Clinical Research - Populace Health (Network) — Tustin, California (28.1 mi)
· Sponsor: Elevara Medicines Limited
Efficacy of Preoperative Administration of Gabapentin in 3rd Molar Dental Extraction.
Dental Pain and Sensation Disorder, Pain, Postoperative
Phase 4
Interventional 98 participants sought
Loma Linda University Health — Loma Linda, California (10.8 mi)
· Sponsor: Loma Linda University
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Prostate Cancer
Phase 4
Interventional 700 participants sought
St. Joseph Hospital — Orange, California (28.3 mi)
· Sponsor: Novartis Pharmaceuticals
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis, Ulcerative Colitis Chronic
Phase 2
Interventional 140 participants sought
Prospective Research Innovations — Rancho Cucamonga, California (16.3 mi)
· Sponsor: Eli Lilly and Company
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
Asthma
Phase 3
Interventional 231 participants sought
Research Site — Orange, California (28.3 mi)
· Sponsor: AstraZeneca
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
Schizophrenia
Phase 3
Interventional 690 participants sought
Reviva site — Riverside, California (1.1 mi)
· Sponsor: Reviva Pharmaceuticals
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Multiple conditions
Phase 2
Interventional 150 participants sought
UC Irvine Health/Chao Family Comprehensive Cancer Center — Orange, California (28.3 mi)
· Sponsor: National Cancer Institute (NCI)
A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin
Growth Hormone Deficiency
N/A
Observational 500 participants sought
Ascendis Investigational Site — Orange, California (28.3 mi)
· Sponsor: Ascendis Pharma Endocrinology Division A/S
Study of Student Flourishing
Healthy
N/A
Interventional 2,500 participants sought
Chapman University — Orange, California (28.3 mi)
· Sponsor: Flourish Science, Inc.
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Ganglioneuroblastoma, Nodular, Neuroblastoma
Phase 3
Interventional 478 participants sought
Loma Linda University Medical Center — Loma Linda, California (10.8 mi)
· Sponsor: National Cancer Institute (NCI)
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Non-small Cell Lung Cancer
Phase 3
Interventional 582 participants sought
Research Site — Orange, California (28.3 mi)
· Sponsor: AstraZeneca
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
NonSegmental Vitiligo
Phase 3
Interventional 180 participants sought
Empire Clinical Research — Pomona, California (22.0 mi)
· Sponsor: Incyte Corporation